???pagination.result.count???
???pagination.result.page???
1
SGK phosphorylates Cdc25 and Myt1 to trigger cyclin B- Cdk1 activation at the meiotic G2/M transition. , Hiraoka D, Hosoda E, Chiba K, Kishimoto T ., J Cell Biol. November 4, 2019; 218 (11): 3597-3611.
The N terminus of Ascl1 underlies differing proneural activity of mouse and Xenopus Ascl1 proteins. , Hardwick LJA, Philpott A., Wellcome Open Res. September 26, 2018; 3 125.
MPF-based meiotic cell cycle control: Half a century of lessons from starfish oocytes. , Kishimoto T ., Proc Jpn Acad Ser B Phys Biol Sci. January 1, 2018; 94 (4): 180-203.
Two new competing pathways establish the threshold for cyclin-B- Cdk1 activation at the meiotic G2/M transition. , Hiraoka D, Aono R, Hanada S, Okumura E, Kishimoto T ., J Cell Sci. August 15, 2016; 129 (16): 3153-66.
Cyclin B- Cdk1 inhibits protein phosphatase PP2A-B55 via a Greatwall kinase-independent mechanism. , Okumura E, Morita A, Wakai M, Mochida S, Hara M, Kishimoto T ., J Cell Biol. March 17, 2014; 204 (6): 881-9.
Greatwall kinase and cyclin B- Cdk1 are both critical constituents of M-phase-promoting factor. , Hara M, Abe Y, Tanaka T, Yamamoto T , Okumura E, Kishimoto T ., Nat Commun. January 1, 2012; 3 1059.
Cyclin aggregation and robustness of bio-switching. , Slepchenko BM, Terasaki M ., Mol Biol Cell. November 1, 2003; 14 (11): 4695-706.
Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. , Okumura E, Fukuhara T, Yoshida H, Hanada Si S, Kozutsumi R, Mori M, Tachibana K, Kishimoto T ., Nat Cell Biol. February 1, 2002; 4 (2): 111-6.